These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27330454)

  • 1. AES Position Statement on Generic Substitution of Antiepileptic Drugs.
    Vossler DG; Anderson GD; Bainbridge J
    Epilepsy Curr; 2016; 16(3):209-11. PubMed ID: 27330454
    [No Abstract]   [Full Text] [Related]  

  • 2. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
    Fong JK; Chan EL; Leung H; Chan I; Chang RS; Fong GC; Fung EL; Lui CH; Fung BB; Poon TL; Siu D; Wong HT; Yeung E; Yung AW; Zhu CX;
    Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians underestimate the frequency of generic carbamazepine substitution: results of a survey and review of the problem.
    Wilner AN
    Epilepsy Behav; 2002 Dec; 3(6):522-525. PubMed ID: 12609245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adverse events related to substitution of generic products in Norway 2005].
    Reppe LA; Stenberg-Nilsen H; Harg P; Hegge AB; Lillefloth AK; Buajordet I
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2696-700. PubMed ID: 19079413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic substitution of antiepileptic drugs.
    Sander JW; Ryvlin P; Stefan H; Booth DR; Bauer J
    Expert Rev Neurother; 2010 Dec; 10(12):1887-98. PubMed ID: 21091318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential problems and recommendations regarding substitution of generic antiepileptic drugs: a systematic review of literature.
    Atif M; Azeem M; Sarwar MR
    Springerplus; 2016; 5():182. PubMed ID: 27026878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies.
    Yamada M; Welty TE
    Ann Pharmacother; 2011 Nov; 45(11):1406-15. PubMed ID: 22028417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic substitution for brand name antiepileptic drugs: a survey.
    Guberman A; Corman C
    Can J Neurol Sci; 2000 Feb; 27(1):37-43. PubMed ID: 10676586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues.
    Crawford P; Feely M; Guberman A; Kramer G
    Seizure; 2006 Apr; 15(3):165-76. PubMed ID: 16504545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic substitution of antiepileptic drugs--a survey of patients' perspectives in Germany and other German-speaking countries.
    Hensler K; Uhlmann C; Porschen T; Benecke R; Rösche J
    Epilepsy Behav; 2013 Apr; 27(1):135-9. PubMed ID: 23416284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antiepileptic drug substitutions on epileptic events requiring acute care.
    Rascati KL; Richards KM; Johnsrud MT; Mann TA
    Pharmacotherapy; 2009 Jul; 29(7):769-74. PubMed ID: 19558250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy: what's the problem with generic antiepileptic drugs? A call to action.
    Miller JW; Anderson GD; Doherty MJ; Poolos NP
    Neurology; 2007 Oct; 69(18):1806-8. PubMed ID: 17967998
    [No Abstract]   [Full Text] [Related]  

  • 13. Generic substitution of antiepileptic drugs: What's a clinician to do?
    Privitera M
    Neurol Clin Pract; 2013 Apr; 3(2):161-164. PubMed ID: 23914324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
    Contin M; Alberghini L; Candela C; Benini G; Riva R
    Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of generic anti-epilepsy drugs in France: survey of neurologists and review of the literature].
    Biraben A; De Toffol B; Semah F; Rouaud T
    Rev Neurol (Paris); 2007 Apr; 163(4):455-61. PubMed ID: 17452947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic substitution in the treatment of epilepsy: patient attitudes and perceptions.
    Ngo SN; Stupans I; McKinnon RA
    Epilepsy Behav; 2013 Jan; 26(1):64-6. PubMed ID: 23220461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current approaches to the use of generic antiepileptic drugs.
    Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
    Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy and generic substitution of antiepileptic drugs: missing in action?
    Welty TE
    Ann Pharmacother; 2007 Jun; 41(6):1065-8. PubMed ID: 17504833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the use of the "not for generic substitution" mention for prescriptions in primary care: a survey with general practitioners.
    Beauvais V; Marque A; Ferté G; Chrusciel J; Souille J; Nazeyrollas P; Sanchez S
    BMC Health Serv Res; 2018 Nov; 18(1):850. PubMed ID: 30419890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
    Rahman MM; Alatawi Y; Cheng N; Qian J; Plotkina AV; Peissig PL; Berg RL; Page D; Hansen RA
    Epilepsy Res; 2017 Sep; 135():71-78. PubMed ID: 28641219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.